Annual CFF
$1.63 M
-$15.76 M-90.61%
01 December 2023
Summary:
NLS Pharmaceutics AG annual cash flow from financing activities is currently $1.63 million, with the most recent change of -$15.76 million (-90.61%) on 01 December 2023. During the last 3 years, it has risen by +$1.13 million (+224.47%). NLSP annual CFF is now -91.97% below its all-time high of $20.34 million, reached on 31 December 2021.NLSP Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NLSP Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -90.6% | - | - |
3 y3 years | +224.5% | - | - |
5 y5 years | +192.8% | - | - |
NLSP Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -92.0% | +224.5% | ||||
5 y | 5 years | -92.0% | +300.9% | ||||
alltime | all time | -92.0% | +300.9% |
NLS Pharmaceutics AG Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | $1.63 M(-90.6%) | - | - |
Dec 2022 | $17.40 M(-14.5%) | - | - |
Dec 2021 | $20.34 M(+3939.3%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | $503.50 K(+23.6%) | - | - |
Dec 2019 | $407.50 K(-27.0%) | - | - |
Dec 2018 | $557.90 K(-91.7%) | - | - |
Dec 2017 | $6.73 M | - | - |
FAQ
- What is NLS Pharmaceutics AG annual cash flow from financing activities?
- What is the all time high annual CFF for NLS Pharmaceutics AG?
- What is NLS Pharmaceutics AG annual CFF year-on-year change?
What is NLS Pharmaceutics AG annual cash flow from financing activities?
The current annual CFF of NLSP is $1.63 M
What is the all time high annual CFF for NLS Pharmaceutics AG?
NLS Pharmaceutics AG all-time high annual cash flow from financing activities is $20.34 M
What is NLS Pharmaceutics AG annual CFF year-on-year change?
Over the past year, NLSP annual cash flow from financing activities has changed by -$15.76 M (-90.61%)